Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)

SHA:600566 Revenue

Hubei Jumpcan Pharmaceutical had revenue of 1.18B CNY in the quarter ending September 30, 2025, a decrease of -33.17%. This brings the company's revenue in the last twelve months to 6.14B, down -31.15% year-over-year. In the year 2024, Hubei Jumpcan Pharmaceutical had annual revenue of 8.02B, down -16.96%.

• Revenue (ttm): 6.14B
• Revenue Growth: -31.15%
• P/S Ratio: 4.16
• Revenue / Employee: 1.22M
• Employees: 5,026
• Market Cap: 25.55B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.02B	-1.64B	-16.96%
Dec 31, 2023	9.65B	658.17M	7.32%
Dec 31, 2022	9.00B	1.37B	17.90%
Dec 31, 2021	7.63B	1.47B	23.77%
Dec 31, 2020	6.16B	-775.02M	-11.17%